# KingMed Diagnostics

Guangzhou Kingmed Diagnostics Group (603882.SS), one of China's largest third-party medical-testing and specimen-network operators.

Source: https://en.bioecon.ru/companies/kingmed/
Updated: 2026-06-25

- Country: China
- Ticker: 603882.SS

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Founded | 2006 | https://finance.yahoo.com/quote/603882.SS/profile/, https://sg.finance.yahoo.com/quote/603882.SS/, https://synapse.patsnap.com/organization/88462e8853b75e60f78b64d9c1e078b7 |
| Headcount | 9,529 employees | https://markets.ft.com/data/equities/tearsheet/profile?s=603882%3ASHH, https://sg.finance.yahoo.com/quote/603882.SS/, https://www.globaldata.com/company-profile/Guangzhou-Kingmed-Diagnostics-Group-Co-Ltd/, https://www.marketscreener.com/quote/stock/GUANGZHOU-KINGMED-DIAGNOS-42644712/company/ |
| Revenue | CNY 6.03 billion (2025 fiscal year) | https://financialfilings.com/companies/guangzhou-kingmed-diagnostics-group-co-ltd/ |
| Certification | CAP and ISO 15189 accreditation | https://financialfilings.com/companies/guangzhou-kingmed-diagnostics-group-co-ltd/ |
| Production site | 49 medical laboratories and nearly 700 cooperative laboratories across China | https://pdf.dfcfw.com/pdf/H2_AN202404251631309252_1.pdf |

Independent sources: finance.yahoo.com, financialfilings.com, globaldata.com, markets.ft.com, marketscreener.com, pdf.dfcfw.com, sg.finance.yahoo.com, synapse.patsnap.com

## Technologies

- [Biospecimen logistics for clinical trials](https://en.bioecon.ru/technology/biospecimen-logistics-for-clinical-trials/)